Loading…

Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug

Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded...

Full description

Saved in:
Bibliographic Details
Published in:Journal of drug delivery science and technology 2013-01, Vol.23 (3), p.225-230
Main Authors: Nabi-Meibodi, M., Navidi, B., Navidi, N., Vatanara, A., Reza Rouini, M., Ramezani, V.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3
cites cdi_FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3
container_end_page 230
container_issue 3
container_start_page 225
container_title Journal of drug delivery science and technology
container_volume 23
creator Nabi-Meibodi, M.
Navidi, B.
Navidi, N.
Vatanara, A.
Reza Rouini, M.
Ramezani, V.
description Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded SLNs were prepared using double emulsification-solvent evaporation method and a Box-Behnken design, based on three independent variables, was used to reduce the number of required experiments. Variable parameters were drug/lipid ratio, w/o phase ratio and the amount of surfactant. It was deduced that SLNs with small particle size, lipophilic feature, high entrapment efficiency and good loading capacity could be produced by this method and experimental design method could be useful for predicting optimum baclofen loaded SLNs with minimum numbers of experiments. Characterization of optimum formulation, provided by evaluation of experimental data, showed no significant difference between calculated and measured data.
doi_str_mv 10.1016/S1773-2247(13)50034-7
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1412518552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1773224713500347</els_id><sourcerecordid>1412518552</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3</originalsourceid><addsrcrecordid>eNqFUMtqwzAQ9KGFhjSfUNAxPbjVw7LsUymhLwjk0NyFIq2Diiy5kh1ov6KfXMcJvfayuwwzs8xk2Q3BdwST8v6dCMFySguxJOyWY8yKXFxksz_4Kluk9IExJgKTgtaz7GfT9ba132CQCcPOAYJ2cMkGn6fgDuB7BAfVhaj6EUNdDBpSQk2Ix9sMeoJDg0a2NcjZbpxe-dCp2FvtICEdfK-st36Pdkq70IAHpBJSZ7b1o3Z6beKwv84uG-USLM57nm2fn7ar13y9eXlbPa5zzQra502NC2pKWpoGylprA5hQxWlV6V1ZU6UEOSbUTNC64kZxBqLBJeG8LAvQbJ4tT7Zjis8BUi9bmzQ4pzyEIUlSEMpJxTkdqfxE1TGkFKGRXbStil-SYHnsXU69y2PBkjA59S7FqHs46WCMcbAQZdIWvAZjI-hemmD_cfgFF_2Ppg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1412518552</pqid></control><display><type>article</type><title>Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug</title><source>ScienceDirect Freedom Collection</source><creator>Nabi-Meibodi, M. ; Navidi, B. ; Navidi, N. ; Vatanara, A. ; Reza Rouini, M. ; Ramezani, V.</creator><creatorcontrib>Nabi-Meibodi, M. ; Navidi, B. ; Navidi, N. ; Vatanara, A. ; Reza Rouini, M. ; Ramezani, V.</creatorcontrib><description>Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded SLNs were prepared using double emulsification-solvent evaporation method and a Box-Behnken design, based on three independent variables, was used to reduce the number of required experiments. Variable parameters were drug/lipid ratio, w/o phase ratio and the amount of surfactant. It was deduced that SLNs with small particle size, lipophilic feature, high entrapment efficiency and good loading capacity could be produced by this method and experimental design method could be useful for predicting optimum baclofen loaded SLNs with minimum numbers of experiments. Characterization of optimum formulation, provided by evaluation of experimental data, showed no significant difference between calculated and measured data.</description><identifier>ISSN: 1773-2247</identifier><identifier>DOI: 10.1016/S1773-2247(13)50034-7</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Baclofen ; Double emulsion ; Entrapment efficiency ; Optimization ; Solid lipid nanoparticles ; solvent evaporation</subject><ispartof>Journal of drug delivery science and technology, 2013-01, Vol.23 (3), p.225-230</ispartof><rights>2013 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3</citedby><cites>FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Nabi-Meibodi, M.</creatorcontrib><creatorcontrib>Navidi, B.</creatorcontrib><creatorcontrib>Navidi, N.</creatorcontrib><creatorcontrib>Vatanara, A.</creatorcontrib><creatorcontrib>Reza Rouini, M.</creatorcontrib><creatorcontrib>Ramezani, V.</creatorcontrib><title>Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug</title><title>Journal of drug delivery science and technology</title><description>Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded SLNs were prepared using double emulsification-solvent evaporation method and a Box-Behnken design, based on three independent variables, was used to reduce the number of required experiments. Variable parameters were drug/lipid ratio, w/o phase ratio and the amount of surfactant. It was deduced that SLNs with small particle size, lipophilic feature, high entrapment efficiency and good loading capacity could be produced by this method and experimental design method could be useful for predicting optimum baclofen loaded SLNs with minimum numbers of experiments. Characterization of optimum formulation, provided by evaluation of experimental data, showed no significant difference between calculated and measured data.</description><subject>Baclofen</subject><subject>Double emulsion</subject><subject>Entrapment efficiency</subject><subject>Optimization</subject><subject>Solid lipid nanoparticles</subject><subject>solvent evaporation</subject><issn>1773-2247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFUMtqwzAQ9KGFhjSfUNAxPbjVw7LsUymhLwjk0NyFIq2Diiy5kh1ov6KfXMcJvfayuwwzs8xk2Q3BdwST8v6dCMFySguxJOyWY8yKXFxksz_4Kluk9IExJgKTgtaz7GfT9ba132CQCcPOAYJ2cMkGn6fgDuB7BAfVhaj6EUNdDBpSQk2Ix9sMeoJDg0a2NcjZbpxe-dCp2FvtICEdfK-st36Pdkq70IAHpBJSZ7b1o3Z6beKwv84uG-USLM57nm2fn7ar13y9eXlbPa5zzQra502NC2pKWpoGylprA5hQxWlV6V1ZU6UEOSbUTNC64kZxBqLBJeG8LAvQbJ4tT7Zjis8BUi9bmzQ4pzyEIUlSEMpJxTkdqfxE1TGkFKGRXbStil-SYHnsXU69y2PBkjA59S7FqHs46WCMcbAQZdIWvAZjI-hemmD_cfgFF_2Ppg</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Nabi-Meibodi, M.</creator><creator>Navidi, B.</creator><creator>Navidi, N.</creator><creator>Vatanara, A.</creator><creator>Reza Rouini, M.</creator><creator>Ramezani, V.</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20130101</creationdate><title>Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug</title><author>Nabi-Meibodi, M. ; Navidi, B. ; Navidi, N. ; Vatanara, A. ; Reza Rouini, M. ; Ramezani, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Baclofen</topic><topic>Double emulsion</topic><topic>Entrapment efficiency</topic><topic>Optimization</topic><topic>Solid lipid nanoparticles</topic><topic>solvent evaporation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nabi-Meibodi, M.</creatorcontrib><creatorcontrib>Navidi, B.</creatorcontrib><creatorcontrib>Navidi, N.</creatorcontrib><creatorcontrib>Vatanara, A.</creatorcontrib><creatorcontrib>Reza Rouini, M.</creatorcontrib><creatorcontrib>Ramezani, V.</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of drug delivery science and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nabi-Meibodi, M.</au><au>Navidi, B.</au><au>Navidi, N.</au><au>Vatanara, A.</au><au>Reza Rouini, M.</au><au>Ramezani, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug</atitle><jtitle>Journal of drug delivery science and technology</jtitle><date>2013-01-01</date><risdate>2013</risdate><volume>23</volume><issue>3</issue><spage>225</spage><epage>230</epage><pages>225-230</pages><issn>1773-2247</issn><abstract>Intrathecal injection of baclofen is the reference treatment for severe spasticity of cerebral-spinal origin. Solid lipid nanoparticles (SLNs) could be considered as a beneficial delivery system for enhancing penetration of drug through the blood brain barrier (BBB). In this study, baclofen- loaded SLNs were prepared using double emulsification-solvent evaporation method and a Box-Behnken design, based on three independent variables, was used to reduce the number of required experiments. Variable parameters were drug/lipid ratio, w/o phase ratio and the amount of surfactant. It was deduced that SLNs with small particle size, lipophilic feature, high entrapment efficiency and good loading capacity could be produced by this method and experimental design method could be useful for predicting optimum baclofen loaded SLNs with minimum numbers of experiments. Characterization of optimum formulation, provided by evaluation of experimental data, showed no significant difference between calculated and measured data.</abstract><pub>Elsevier B.V</pub><doi>10.1016/S1773-2247(13)50034-7</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1773-2247
ispartof Journal of drug delivery science and technology, 2013-01, Vol.23 (3), p.225-230
issn 1773-2247
language eng
recordid cdi_proquest_miscellaneous_1412518552
source ScienceDirect Freedom Collection
subjects Baclofen
Double emulsion
Entrapment efficiency
Optimization
Solid lipid nanoparticles
solvent evaporation
title Optimized double emulsion-solvent evaporation process for production of solid lipid nanoparticles containing baclofene as a lipid insoluble drug
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T02%3A41%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimized%20double%20emulsion-solvent%20evaporation%20process%20for%20production%20of%20solid%20lipid%20nanoparticles%20containing%20baclofene%20as%20a%20lipid%20insoluble%20drug&rft.jtitle=Journal%20of%20drug%20delivery%20science%20and%20technology&rft.au=Nabi-Meibodi,%20M.&rft.date=2013-01-01&rft.volume=23&rft.issue=3&rft.spage=225&rft.epage=230&rft.pages=225-230&rft.issn=1773-2247&rft_id=info:doi/10.1016/S1773-2247(13)50034-7&rft_dat=%3Cproquest_cross%3E1412518552%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c342t-f9042d626dfe69ccde012a5288cb692aa710142c372985da53e7f06155664ec3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1412518552&rft_id=info:pmid/&rfr_iscdi=true